Neurometabolic disorders or the neurogenetic are abonormalities that affects the brain functions. The disorders are seen in all age groups. The disorders are caused due to the abnormal functions of the gene that can lead to various chronic diseases and rare diseases. The disorder does not have specific treatment or cures however, precise diagnosis is important to understand the underlying cause so that future treatments can be offered.
MARKET DYNAMICS
The neurometabolic disorders market is anticipated due to the key driving factors such as rising healthcare expenditures, rising awareness about the diseases, rise in the technological advancement and others. The market is likely to gain growth opportunities owing to the developments in the technologies for genomics that are likely to offer treatments for the rare diseases.
MARKET SCOPE
The "Global Neurometabolic Disorders Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of neurometabolic disorders market with detailed market segmentation by disease type, route of administration and geography. The global neurometabolic disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neurometabolic disorders market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global neurometabolic disorders market is segmented on the basis of disease type and route of administration. Based on the disease type the market is segmented as fabry disease, gaucher's disease, pompe disease, maroteaux-lamy syndrome and others. Based on the route of administration the market is classified as parenteral and oral.
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurometabolic disorders market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurometabolic disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting neurometabolic disorders market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neurometabolic disorders market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurometabolic disorders market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurometabolic disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting neurometabolic disorders market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neurometabolic disorders market in these regions.
MARKET PLAYERSThe reports cover key developments in the neurometabolic disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from neurometabolic disorders market are anticipated to lucrative growth opportunities in the future with the rising demand for neurometabolic disorders market in the global market. Below mentioned is the list of few companies engaged in the neurometabolic disorders market.
The report also includes the profiles of key neurometabolic disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Amicus Therapeutics, Inc.
- Zywie LLC (ExSAR Corporation)
- Greenovation Biotech GmbH
- ISU ABXIS
- Protalix Biotherapeutics
- BioMarin Pharmaceutical Inc
- Genzyme Corporation (Sanofi)
- Shire (Takeda Pharmaceutical Company Limited)
- Celerion
- Orchard Therapeutics plc.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurometabolic Disorders Market - By Disease Type
1.3.2 Neurometabolic Disorders Market - By Route of Administration
1.3.3 Neurometabolic Disorders Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. NEUROMETABOLIC DISORDERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROMETABOLIC DISORDERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NEUROMETABOLIC DISORDERS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROMETABOLIC DISORDERS - GLOBAL MARKET OVERVIEW
6.2. NEUROMETABOLIC DISORDERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROMETABOLIC DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. FABRY DISEASE
7.3.1. Overview
7.3.2. Fabry Disease Market Forecast and Analysis
7.4. GAUCHER'S DISEASE
7.4.1. Overview
7.4.2. Gaucher's Disease Market Forecast and Analysis
7.5. POMPE DISEASE
7.5.1. Overview
7.5.2. Pompe Disease Market Forecast and Analysis
7.6. MAROTEAUX-LAMY SYNDROME
7.6.1. Overview
7.6.2. Maroteaux-Lamy Syndrome Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. NEUROMETABOLIC DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. PARENTERAL
8.3.1. Overview
8.3.2. Parenteral Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
9. NEUROMETABOLIC DISORDERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neurometabolic Disorders Market Overview
9.1.2 North America Neurometabolic Disorders Market Forecasts and Analysis
9.1.3 North America Neurometabolic Disorders Market Forecasts and Analysis - By Disease Type
9.1.4 North America Neurometabolic Disorders Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Neurometabolic Disorders Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neurometabolic Disorders Market
9.1.5.1.1 United States Neurometabolic Disorders Market by Disease Type
9.1.5.1.2 United States Neurometabolic Disorders Market by Route of Administration
9.1.5.2 Canada Neurometabolic Disorders Market
9.1.5.2.1 Canada Neurometabolic Disorders Market by Disease Type
9.1.5.2.2 Canada Neurometabolic Disorders Market by Route of Administration
9.1.5.3 Mexico Neurometabolic Disorders Market
9.1.5.3.1 Mexico Neurometabolic Disorders Market by Disease Type
9.1.5.3.2 Mexico Neurometabolic Disorders Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Neurometabolic Disorders Market Overview
9.2.2 Europe Neurometabolic Disorders Market Forecasts and Analysis
9.2.3 Europe Neurometabolic Disorders Market Forecasts and Analysis - By Disease Type
9.2.4 Europe Neurometabolic Disorders Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Neurometabolic Disorders Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neurometabolic Disorders Market
9.2.5.1.1 Germany Neurometabolic Disorders Market by Disease Type
9.2.5.1.2 Germany Neurometabolic Disorders Market by Route of Administration
9.2.5.2 France Neurometabolic Disorders Market
9.2.5.2.1 France Neurometabolic Disorders Market by Disease Type
9.2.5.2.2 France Neurometabolic Disorders Market by Route of Administration
9.2.5.3 Italy Neurometabolic Disorders Market
9.2.5.3.1 Italy Neurometabolic Disorders Market by Disease Type
9.2.5.3.2 Italy Neurometabolic Disorders Market by Route of Administration
9.2.5.4 Spain Neurometabolic Disorders Market
9.2.5.4.1 Spain Neurometabolic Disorders Market by Disease Type
9.2.5.4.2 Spain Neurometabolic Disorders Market by Route of Administration
9.2.5.5 United Kingdom Neurometabolic Disorders Market
9.2.5.5.1 United Kingdom Neurometabolic Disorders Market by Disease Type
9.2.5.5.2 United Kingdom Neurometabolic Disorders Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neurometabolic Disorders Market Overview
9.3.2 Asia-Pacific Neurometabolic Disorders Market Forecasts and Analysis
9.3.3 Asia-Pacific Neurometabolic Disorders Market Forecasts and Analysis - By Disease Type
9.3.4 Asia-Pacific Neurometabolic Disorders Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Neurometabolic Disorders Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Neurometabolic Disorders Market
9.3.5.1.1 Australia Neurometabolic Disorders Market by Disease Type
9.3.5.1.2 Australia Neurometabolic Disorders Market by Route of Administration
9.3.5.2 China Neurometabolic Disorders Market
9.3.5.2.1 China Neurometabolic Disorders Market by Disease Type
9.3.5.2.2 China Neurometabolic Disorders Market by Route of Administration
9.3.5.3 India Neurometabolic Disorders Market
9.3.5.3.1 India Neurometabolic Disorders Market by Disease Type
9.3.5.3.2 India Neurometabolic Disorders Market by Route of Administration
9.3.5.4 Japan Neurometabolic Disorders Market
9.3.5.4.1 Japan Neurometabolic Disorders Market by Disease Type
9.3.5.4.2 Japan Neurometabolic Disorders Market by Route of Administration
9.3.5.5 South Korea Neurometabolic Disorders Market
9.3.5.5.1 South Korea Neurometabolic Disorders Market by Disease Type
9.3.5.5.2 South Korea Neurometabolic Disorders Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neurometabolic Disorders Market Overview
9.4.2 Middle East and Africa Neurometabolic Disorders Market Forecasts and Analysis
9.4.3 Middle East and Africa Neurometabolic Disorders Market Forecasts and Analysis - By Disease Type
9.4.4 Middle East and Africa Neurometabolic Disorders Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Neurometabolic Disorders Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neurometabolic Disorders Market
9.4.5.1.1 South Africa Neurometabolic Disorders Market by Disease Type
9.4.5.1.2 South Africa Neurometabolic Disorders Market by Route of Administration
9.4.5.2 Saudi Arabia Neurometabolic Disorders Market
9.4.5.2.1 Saudi Arabia Neurometabolic Disorders Market by Disease Type
9.4.5.2.2 Saudi Arabia Neurometabolic Disorders Market by Route of Administration
9.4.5.3 U.A.E Neurometabolic Disorders Market
9.4.5.3.1 U.A.E Neurometabolic Disorders Market by Disease Type
9.4.5.3.2 U.A.E Neurometabolic Disorders Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neurometabolic Disorders Market Overview
9.5.2 South and Central America Neurometabolic Disorders Market Forecasts and Analysis
9.5.3 South and Central America Neurometabolic Disorders Market Forecasts and Analysis - By Disease Type
9.5.4 South and Central America Neurometabolic Disorders Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Neurometabolic Disorders Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neurometabolic Disorders Market
9.5.5.1.1 Brazil Neurometabolic Disorders Market by Disease Type
9.5.5.1.2 Brazil Neurometabolic Disorders Market by Route of Administration
9.5.5.2 Argentina Neurometabolic Disorders Market
9.5.5.2.1 Argentina Neurometabolic Disorders Market by Disease Type
9.5.5.2.2 Argentina Neurometabolic Disorders Market by Route of Administration
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEUROMETABOLIC DISORDERS MARKET, KEY COMPANY PROFILES
11.1. AMICUS THERAPEUTICS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ZYWIE LLC (EXSAR CORPORATION)
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GREENOVATION BIOTECH GMBH
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ISU ABXIS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PROTALIX BIOTHERAPEUTICS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOMARIN PHARMACEUTICAL INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GENZYME CORPORATION (SANOFI)
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CELERION
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ORCHARD THERAPEUTICS PLC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Amicus Therapeutics, Inc.
2. Zywie LLC (ExSAR Corporation)
3. Greenovation Biotech GmbH
4. ISU ABXIS
5. Protalix Biotherapeutics
6. BioMarin Pharmaceutical Inc
7. Genzyme Corporation (Sanofi)
8. Shire (Takeda Pharmaceutical Company Limited)
9. Celerion
10. Orchard Therapeutics plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For